Updated Jul 16, 2026
Sandler Laura Lee has filed 3 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $1.40M.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-01 | ORKA | Oruka Therapeutics, Inc. | S — Open-market sale | 500 | $95.47 | $48K |
| 2026-07-01 | ORKA | Oruka Therapeutics, Inc. | S — Open-market sale | 2.3K | $94.75 | $214K |
| 2026-07-01 | ORKA | Oruka Therapeutics, Inc. | S — Open-market sale | 2.2K | $93.85 | $210K |
| 2026-07-01 | ORKA | Oruka Therapeutics, Inc. | M — Option exercise | 5.0K | $7.80 | $39K |
| 2026-06-15 | ORKA | Oruka Therapeutics, Inc. | S — Open-market sale | 600 | $69.69 | $42K |
| 2026-05-01 | ORKA | Oruka Therapeutics, Inc. | S — Open-market sale | 100 | $68.48 | $7K |
| 2026-05-01 | ORKA | Oruka Therapeutics, Inc. | S — Open-market sale | 200 | $67.16 | $13K |
| 2026-05-01 | ORKA | Oruka Therapeutics, Inc. | S — Open-market sale | 400 | $66.06 | $26K |
| 2026-05-01 | ORKA | Oruka Therapeutics, Inc. | S — Open-market sale | 300 | $65.10 | $20K |
| 2026-05-01 | ORKA | Oruka Therapeutics, Inc. | S — Open-market sale | 1.8K | $64.15 | $115K |
| 2026-05-01 | ORKA | Oruka Therapeutics, Inc. | S — Open-market sale | 2.2K | $62.58 | $138K |
| 2026-05-01 | ORKA | Oruka Therapeutics, Inc. | M — Option exercise | 5.0K | $7.80 | $39K |
| 2026-03-17 | ORKA | Oruka Therapeutics, Inc. | S — Open-market sale | 600 | $41.30 | $25K |
| 2026-03-02 | ORKA | Oruka Therapeutics, Inc. | S — Open-market sale [10b5-1] | 2.7K | $33.81 | $90K |
| 2026-03-02 | ORKA | Oruka Therapeutics, Inc. | S — Open-market sale [10b5-1] | 2.3K | $33.28 | $77K |
| 2026-03-02 | ORKA | Oruka Therapeutics, Inc. | M — Option exercise [10b5-1] | 5.0K | $7.80 | $39K |
| 2026-01-23 | ORKA | Oruka Therapeutics, Inc. | A — Grant or award | 32.5K | $0.00 | |
| 2026-01-03 | ORKA | Oruka Therapeutics, Inc. | S — Open-market sale [10b5-1] | 1.1K | $29.75 | $33K |
| 2026-01-03 | ORKA | Oruka Therapeutics, Inc. | S — Open-market sale [10b5-1] | 3.1K | $29.08 | $91K |
| 2026-01-03 | ORKA | Oruka Therapeutics, Inc. | S — Open-market sale [10b5-1] | 8.7K | $28.17 | $246K |
Sandler Laura Lee is a corporate insider — currently tracked as Chief Operating Officer of Oruka Therapeutics, Inc. (ORKA). InsiderAlpha tracks every SEC Form 4 filing in real time.
3 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 16 open-market sales ($1.40M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Sandler Laura Lee profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.